Raltegravir Potassium Api - Pharmaceutical Active Ingredient

Raltegravir Potassium API (CAS No. 871038‑72‑1) is a high‑purity HIV integrase strand transfer inhibitor (INSTI) Active Pharmaceutical Ingredient widely used in antiretroviral therapy (ART) formulations. Raltegravir works by inhibiting the HIV integrase enzyme, preventing the insertion of viral genetic material into the DNA of human host cells, thereby blocking viral replication at an early stage of the infection cycle. Raltegravir Potassium is commonly used in combination antiretroviral regimens to: Control HIV‑1 infection Reduce viral load in the bloodstream Preserve immune system function Lower the risk of AIDS‑related complications While it does not cure HIV, Raltegravir plays a critical role in long‑term HIV management due to its strong efficacy, favorable safety profile, and minimal drug‑drug interactions. 🧪 Specifications & Details Product Name: Raltegravir Potassium Synonyms: Raltegravir Potassium Salt Product Code: ATM157RALT Grade: BP / USP / EP CAS Number: 871038‑72‑1 Molecular Formula: C20H20FKN6O5 Molecular Weight: 482.5 g/mol COA & MSDS: Available on request 📦 Packaging & Storage Packaging: 25 Kg HDPE drums with double liner bags inside (export‑worthy) Storage Condition: Store in air‑tight containers Protect from direct light and moisture ⭐ Key Features Manufactured in WHO‑GMP compliant facilities High‑purity integrase inhibitor API Excellent chemical stability with controlled impurity profile Suitable for oral solid dosage forms (tablets, film‑coated tablets) Ideal for fixed‑dose combination antiretroviral formulations Consistent batch‑to‑batch quality Export‑grade API with complete regulatory documentation (COA, MSDS) 💊 Applications Used in regulated pharmaceutical formulations for: HIV‑1 antiretroviral therapy (ART) Integrase‑inhibitor‑based treatment regimens Combination antiviral tablets Long‑term viral suppression therapies Global HIV treatment and public‑health programs 🔍 Keywords for Better Reach Raltegravir Potassium API, Raltegravir Bulk Drug, HIV Integrase Inhibitor API, Antiretroviral Raw Material, HIV Treatment API, INSTI Bulk Drug, Active Pharmaceutical Ingredient, CAS 871038‑72‑1, USP Grade, EP Grade, BP Grade, WHO‑GMP Certified, Pharmaceutical Export. #RaltegravirPotassium #Raltegravir #PharmaceuticalAPI #Antiretroviral #HIVTreatment #IntegraseInhibitor #INSTI #BulkDrugs #ActiveIngredient #PharmaExport #CAS871038721 #USPGrade #EPGrade #BPGrade About the Company GST Registration Date: 2020 Legal Status of Firm: Proprietorship Number of Employees: 11 To 25 People Annual Turnover: 40 L - 1.5 Cr